July 11, 2006 - Yokneam, Israel
Lumenis® Ltd., a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications, announced today the launch of ActiveFX, an effective, single treatment procedure for skin rejuvenation. The ActiveFX procedure can be used to treat fine lines, wrinkles, skin laxity, discoloration (e.g., freckles, "age spots," etc.), and other effects of aging and sun damage.
"Recent trends indicate younger and more active patients are increasingly seeking skin rejuvenation procedures to treat photoaging that is noticeable, though not yet severe. At the same time, they are averse to procedures that require multiple visits or a lengthy recovery..For these patients, efficacy and convenience are both important – they want clearly visible results quickly, but they don't want a lot of 'downtime' after the treatment," commented Avner Raz, Lumenis President and CEO.
"Last year we introduced the Aluma™ Skin Renewal System, an ideal choice for those preferring an effective, zero 'downtime,' multiple-treatment regimen for fine lines, modest wrinkles and loose skin. With ActiveFX, we now have the optimal procedure for those willing to accept a few days of 'downtime' for impactful results in a single treatment session. The introduction of ActiveFX further underscores Lumenis' commitment to offer the broadest range of effective aesthetic procedures for both patients and practitioners," added Mr. Raz.
"I am very excited about the new ActiveFX procedure – it provides physicians with an opportunity to offer patients an extremely effective, safe, convenient, single-treatment choice," noted Barry E. DiBernardo, M.D. of Montclair, New Jersey, who has already performed several ActiveFX procedures. "ActiveFX utilizes an ideal type of energy – CO2 laser energy, to provide the predictable, clearly noticeable results that patients require, in a very fast, single-treatment approach,” added Dr. DiBernardo.
Dr. James A. Heinrich of Mission Viejo, California has already treated many patients with the new procedure. “With the ActiveFX procedure, a complete face can be treated in less than 30 minutes, and the required downtime can be as short as four days or so – essentially a long weekend. For most patients, desired results are clearly visible by the fourth or fifth day after treatment. And since the procedure uses CO2 energy, which penetrates into the dermis and stimulates new collagen growth, additional improvement continues for months after the treatment. With proper care to avoid the harmful effects of sunlight, the improvement can last for several years," added Dr. Heinrich.
About the ActiveFX Procedure
The ActiveFX procedure works by applying the CO2 laser energy in a very narrow, scanned beam. This results in the creation of very tiny columns of thermal damage that penetrate deep down to the dermis and stimulate the growth of new collagen. The energy is applied in a "fractional" way – that is, the tiny columns of thermal damage are spaced so that tissue between each is spared – which results in a faster healing process. ActiveFX differs from other aesthetic procedures employing fractional approaches because it uses CO2 laser energy, which is considered by many the optimal treatment for photoaged and environmentally damaged skin.
CO2 energy is the ideal because it treats the areas of discoloration closer to the surface and also penetrates deep into the dermis, eliminating damaged cells and stimulating the growth of new collagen. This new collagen lifts and supports the skin’s surface. For patients desiring dramatic results and willing to accept downtime, traditional CO2 resurfacing remains a very good option. However, for active patients desiring significant effects from a single treatment with very little downtime, the ActiveFX procedure provides an exciting alternative.
The ActiveFX procedure is a unique, proprietary application of the Lumenis UltraPulse® Encore™ system. This system uses CO2 laser energy to perform ActiveFX and other skin rejuvenation procedures, as well as various incisional and excisional dermatologic and surgical procedures.
Lumenis is a global developer, manufacturer and seller of laser and light-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis and its products, log onto: http://www.lumenis.com